We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BIONEER

Provides solutions for molecular diagnostics including nucleic acid extraction instruments, real-time PCR instruments... read more Featured Products: More products

Download Mobile App





Bioneer Presents Near-Patient POC Molecular Diagnostic System at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022
Print article
Image: IRON-qPCR POC molecular diagnostic system helps obtain precise results while being close to the patient (Photo courtesy of Bioneer)
Image: IRON-qPCR POC molecular diagnostic system helps obtain precise results while being close to the patient (Photo courtesy of Bioneer)

Bioneer Corp. (Daejeon, Korea) is demonstrating its state-of-the-art molecular biology products and technologies at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany.

At MEDICA 2022, Bioneer is showcasing the AccuLoader which guides users to load samples into the correct wells of a multi-well plate by scanning each sample barcode and automatically moving the dispensing hole to the correct well. Loading conditions and sample information are easily managed using the included tablet and dedicated AccuLoader application. In addition, users can quickly pool a large number of samples without human error using the pool sample setting, and the sample shield and filter prevent cross-contamination while samples are being loaded. Bioneer is also highlighting the ExiPrep 96 Lite automated nucleic acid extractor with high capacity which has built-in protocols optimized for various kit applications for the extraction of nucleic acid. ExiPrep 96 Lite can extract viral RNA in 30 minutes with the Protonion Viral RNA Kit, which does not contain EtOH to prevent PCR inhibition and rapid extraction speed.

Alongside the ExiPrep 96 Lite, Bioneer is showcasing the ExiStation series of automated molecular diagnostic system composed of the ExiPrep 16 Dx nucleic acid extractor and Exicycler 96 Real-Time PCR. The system configuration is flexible and can connect up to three ExiPrep 16 Dx. The ExiStation 48 is composed of ExiPrep 48Dx nucleic acid extractor and the Exicycler 96 Real-Time PCR. The ExiStation series of automated molecular diagnostic system has been developed with Bioneer’s patented technologies and are adjustable to lab conditions. The ExiStation series are optimized for vacuum-dried premix kits and adapted with four-layer contamination protection for constant test accuracy.

At MEDICA 2022, Bioneer is highlighting its new IRON-qPCR near-patient POC molecular diagnostic system which is fully automated and requires the user to just put the sample in to get the data out. The assays are done within 30 minutes and are suitable for near-patient diagnosis. The IRON-qPCR is also a two-cartridge type instrument with user-friendly operation steps using the touch screen, and can handle up to 40 pathogens at once for syndrome diagnosis. Visitors to Bioneer’s booth at MEDICA 2022 can experience the ExiStation FA 96/384 fully automated molecular diagnostic system that is capable of automated de-capping and capping primary sample tubes inside the system. It does not require negative-pressure facility such as BSC and helps generate consistent results without human error. Visitors can also experience the LH 384 fully automated liquid handler that transfers extracted nucleic acid to PCR preparation. It transfers extracted nucleic acid from 96 well plates to a 96/384 well plate or tubes. With Bioneer’s premix cartridges, user can easily prepare samples for PCR by simply sealing the PCR plate or tubes.

Related Links:
Bioneer Corp.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.